June 21, 2022, VistaGen Therapeutics Inc. (NASDAQ: VTGN) trading session started at the price of $1.02, that was 7.23% jump from the session before. During the day, the shares moved up to $1.07 and dropped to $1.02 before settling in for the closing price of $0.99. A 52-week range for VTGN has been $0.87 – $3.55.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
When this article was written, the company’s average yearly earnings per share was at 2.20%. With a float of $150.27 million, this company’s outstanding shares have now reached $202.33 million.
The extent of productivity of a business whose workforce counts for 31 workers is very important to gauge.
VistaGen Therapeutics Inc. (VTGN) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward VistaGen Therapeutics Inc. stocks. The insider ownership of VistaGen Therapeutics Inc. is 0.20%, while institutional ownership is 69.10%. The most recent insider transaction that took place on Sep 07, was worth 93,750. In this transaction VP, CFO AND SECRETARY of this company sold 30,000 shares at a rate of $3.12, taking the stock ownership to the 72,786 shares. Before that another transaction happened on Aug 17, when Company’s PRES./CHIEF SCIENTIFIC OFFICER bought 3,750 for $2.73, making the entire transaction worth $10,238. This insider now owns 34,641 shares in total.
VistaGen Therapeutics Inc. (VTGN) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/30/2021, it has been observed that the corporation posted -$0.05 earnings per share (EPS) during the time that was better than consensus figure (set at -$0.07) by $0.02. This company achieved a net margin of -1646.09 while generating a return on equity of -41.59. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.20% per share during the next fiscal year.
VistaGen Therapeutics Inc. (NASDAQ: VTGN) Trading Performance Indicators
You can see what VistaGen Therapeutics Inc. (VTGN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 13.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 138.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.37, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of VistaGen Therapeutics Inc. (VTGN)
The latest stats from [VistaGen Therapeutics Inc., VTGN] show that its last 5-days average volume of 1.21 million was inferior to 1.35 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 52.72%. Additionally, its Average True Range was 0.08.
During the past 100 days, VistaGen Therapeutics Inc.’s (VTGN) raw stochastic average was set at 20.65%, which indicates a significant decrease from 54.29% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.49% in the past 14 days, which was lower than the 80.33% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2024, while its 200-day Moving Average is $1.7536. Now, the first resistance to watch is $1.0800. This is followed by the second major resistance level at $1.1000. The third major resistance level sits at $1.1300. If the price goes on to break the first support level at $1.0300, it is likely to go to the next support level at $1.0000. The third support level lies at $0.9800 if the price breaches the second support level.
VistaGen Therapeutics Inc. (NASDAQ: VTGN) Key Stats
There are 206,528K outstanding shares of the company, which has a market capitalization of 208.04 million. As of now, sales total 1,090 K while income totals -17,930 K. Its latest quarter income was 360 K while its last quarter net income were -10,540 K.